Impact of the COVID-19 pandemic on lung cancer screening utilization and outcome: a health examination center retrospective study
Authors:
Open Access
- 28 June 2025
- journal article
- public health
- Published by Taylor & Francis in Annals of Medicine
- Vol. 57 (1)
Abstract
The coronavirus disease 2019 (COVID-19) pandemic has disrupted healthcare systems, significantly affecting preventive services such as low-dose computed tomography (LDCT) for lung cancer screening. We aimed to evaluate the pandemic’s impact on LDCT screening practices at Kaohsiung Veterans General Hospital, focusing on the changes in participation rates, Lung-RADS categories, and lung cancer diagnoses to guide the development of interventions for improving screening programs and early detection during health crises. A retrospective cohort of 56,730 individuals who underwent health examinations between 2017 and 2023 was analyzed. Data on demographics, smoking history, family history of lung cancer, and eligibility for LDCT subsidies in Taiwan were obtained. Screening utilization and outcomes were cross-referenced with cancer registries and imaging databases. A subset of 17,743 individuals who underwent LDCT were examined to determine the pre- and post-COVID19 differences in smoking prevalence, family history, high-risk Lung Imaging Reporting and Data System (Lung-RADS) categories (3 or 4), and lung cancer diagnoses. Following the implementation of the level 3 alert, notable shifts were observed in smoking habits and lung cancer screening eligibility. The prevalence of heavy smokers (≥30 pack-years) declined from 6.9% before the alert to 6.1% after (p = 0.002). Conversely, the proportion of individuals with a family history of lung cancer qualifying for LDCT screening increased significantly from 6.0% to 6.6% (p = 0.009). Additionally, the prevalence of lung cancer diagnoses among individuals with high-risk Lung-RADS categories (Lung-RADS 3 or 4) decreased significantly from 21.5% before the alert to 13.4% after (p = 0.037). The pandemic disrupted LDCT screening, reducing access for high-risk smokers while increasing non-smoker participation. High-risk nodules declined but partially recovered post-pandemic. Future policies must prioritize high-risk individuals, optimize resources, and enhance early detection to improve outcomes and crisis preparedness.Keywords
Funding Information
- Kaohsiung Veterans General Hospital (KSVGH-114-062, KSVGH-114-D03-1)
- National Science and Technology Council (NSTC 113-2314-B-075B-005.)
This publication has 63 references indexed in Scilit:
- Reduced Lung-Cancer Mortality with Volume CT Screening in a Randomized TrialNew England Journal of Medicine, 2020
- Cancer screening: A modest proposal for preventionCleveland Clinic Journal of Medicine, 2019
- Smoking as a risk factor for lung cancer in women and men: a systematic review and meta-analysisBMJ Open, 2018
- Effectiveness of reminder strategies on cancer screening adherence: a randomised controlled trialBritish Journal of General Practice, 2018
- Disparities in Cancer Screening Practices among Minority and Underrepresented PopulationsSeminars in Oncology Nursing, 2017
- Assessment of Selection Criteria for Low-Dose Lung Screening CT Among Asian Ethnic Groups in Taiwan: From Mass Screening to Specific Risk-Based Screening for Non-Smoker Lung CancerClinical Lung Cancer, 2016
- Lung Cancer and Prognosis in Taiwan: A Population-Based Cancer RegistryJournal of Thoracic Oncology, 2013
- Tobacco and Lung Cancer: Risks, Trends, and Outcomes in Patients with CancerAmerican Society of Clinical Oncology Educational Book, 2013
- Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic ScreeningNew England Journal of Medicine, 2011
- Non-Small Cell Lung Cancer: Epidemiology, Risk Factors, Treatment, and SurvivorshipMayo Clinic Proceedings, 2008